Keary Dunn

Keary Dunn is a seasoned executive in the pharmaceutical and biotechnology sectors, currently serving as the Executive Vice President, General Counsel, and Head of Business Development at Celularity, Inc. His professional background includes significant roles in legal and compliance within the industry.

Professional Background

• Current Position: Dunn holds a prominent role at Celularity, Inc., where he oversees legal affairs and business development strategies.
• Previous Experience: He has also served as the Chief Legal Officer and Compliance Officer at TG Therapeutics, Inc., indicating a strong focus on regulatory compliance and corporate governance in his career.

Education

Dunn is an alumnus of George Mason University School of Law, which has equipped him with a solid foundation in legal principles applicable to the biotech field.

Recognition

He has been featured in industry publications, highlighting his contributions to the field and his leadership within Celularity. His insights and expertise are acknowledged through various professional engagements, including posts on platforms like LinkedIn.

Dunn's extensive experience in legal matters, combined with his leadership roles, positions him as a key figure in navigating the complexities of the biotech landscape.